IonWorks Quattro Automated Patch Clamp System for High-Throughput Ion Channel Screening
Ion channels are a viable and under- represented target class in the pharmaceutical industry. Conventional patch clamping of a single cell at a time, the "gold standard" for studying ion channels, is labor intensive and not amenable to screening large numbers of compounds in early stage drug discovery. As a result, surrogate measures of ion channel activity, such as ligand displacement, ionic flux and membrane potential are used, but these assays cannot maintain a population of ion channels in a particular conformational state due to the lack of voltage control.
Recent advances in planar patch clamp technology commenced the era of ion channel screening using a direct electrophysiological assay, and several instruments are commercially available, including the IonWorks® HT and PatchXpress® 7000A systems from Molecular Devices. Although these systems offer considerably higher throughput than conventional patch clamping, there is still a pressing need to match the throughput of surrogate assays while simultaneously driving down the per compound assay costs. To achieve such a goal, Molecular Devices developed the IonWorks® Quattro™ system with Population Patch Clamp™ (PPC) technology.
Charting Kidney Cancer Metabolism Changes in cell metabolism are increasingly recognized as an important way tumors develop and progress, yet these changes are hard to measure and interpret. A new tool designed by MSK scientists allows users to identify metabolic changes in kidney cancer tumors that may one day be targets for therapy.Insights into the Function of the Main Class of Drug Targets About thirty percent of all medical drugs such as beta-blockers or antidepressants interact with certain types of cell surface proteins called G protein coupled receptors.Visualizing a Cancer Drug Target at Atomic Resolution Using cryo-electron microscopy, researchers were able to view, in atomic detail, the binding of a potential small molecule drug to a key protein in cancer cells.Honey’s Potential to Save Lives The healing powers of honey have been known for thousands of years. 3-D Printed Lifelike Liver Tissue for Drug Screening A team led by engineers at the University of California, San Diego has 3D-printed a tissue that closely mimics the human liver's sophisticated structure and function. The new model could be used for patient-specific drug screening and disease modeling. Cytoskeleton Crew Findings confirm sugar's role in helping cancers survive by changing cellular architecture.Biomarker for Recurring HPV-Linked Oropharyngeal Cancers A look-back analysis of HPV infection antibodies in patients treated for oropharyngeal (mouth and throat) cancers linked to HPV infection suggests at least one of the antibodies could be useful in identifying those at risk for a recurrence of the cancer, say scientists at the Johns Hopkins University. Valvena, GSK Sign New R&D Collaboration Valneva to supply process development services for EB66® -based Influenza vaccines. Light Signals from Living Cells Fluorescent protein markers delivered under high pressure.Cellular 'Relief Valve' A team led by scientists at The Scripps Research Institute (TSRI) has solved a long-standing mystery in cell biology by showing essentially how a key “relief-valve” in cells does its job.